Angiotensin-converting enzyme genotype and renal allograft survival

Journal of the American Society of Nephrology

Volumn 8, Issue 8, 1997, Pages 1319-1323

  Beige, Joachim ^a   Scherer, Sabine ^b   Weber, Angela ^a   Engeli, Stefan ^a   Offermann, Gerd ^a   Opelz, Gerhard ^b   Distler, Armin ^a   Sharma, Arya M ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0030730575     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hosteller TH: Chronic transplant rejection. Kidney Int 46: 266-279, 1994
2. Crocker B, Ramos EL: Pathology of the renal allograft. In: Renal Pathology, edited by Tischer C, Brenner B, Philadelphia, Lippincott, 1989, pp 1518-1554
3. Bresticker M, Nelson J, Huang C, Wolf J, Anderson B: Plasma renin activity in renal transplant patients with hypertension. Am J Hypertens 4: 623-626, 1991
4. Luke RG: Pathophysiology and treatment of posttransplant hypertension. J Am Soc Nephrol 2: S37-S44, 1991
5. Rigat B, Hubert C, Aihenc Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346, 1990
6. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51: 197-205, 1992
7. Rosenberg ME, Smith LJ, Correa Rotter R, Hosteller TH: The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45: 403-410, 1994
8. Erdos EG: Angiotensin I converting enzyme and the changes in our concepts through the years [Lecture]. Hypertension 16: 363-370, 1990
9. Friedland J, Setton C, Silverstein E: Induction of angiotensin converting enzyme in human monocytes in culture. Biochem Biophys Res Commun 83: 843-849, 1978
10. Costerousse O, Allegrini J, Lopez M, Aihenc Gelas F: Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 290: 33-40, 1993
11. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, Passa P, Alhenc-Gelas F: Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384-388, 1994
12. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, Ishigami M, Amagasaki Y, Ohara T, Shimatake H: Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 70: 455-459, 1995
13. Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, Iwase M, Fujishima M: Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 39: 97-102, 1996
14. Ohno T, Kawazu S, Tomono S: Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism 45: 218-222, 1996
15. Yorioka T, Suehiro T, Yasuoka N, Hashimoto K, Kawada M: Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin Nephrol 44: 80-85, 1995
16. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O: Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96: 2162-2169, 1995
17. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Rodger RS, Junor BJ, Briggs JD, Connell JM, Jardine AG: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 345: 1540-1542, 1995
18. Schmidt S, Schöne N, Ritz E: Diabetic nephropathy study group: Association of ACE gene polymorphism and diabetic nephropathy. Kidney Int 47: 1176-1181, 1995
19. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44: 489-494, 1995
20. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SLC, Gibson SP, Khatoon A, MacDonald F, Rowe BR, Dunger DB, Dean JD, Davies SJ, Webber J, Smith PR, Mackin P, Marshall SM, Adu D, Morris PJ, Todd JA, Barnett AH, Boulton AJ, Bain SC: Examination of two genetic polymorphisms within the renin-angiotensin system: No evidence for an association with nephropathy in IDDM. Diabetologia 39: 1108-1114, 1996
21. Ringel J, Beige J, Kunz R, Distler A, Sharma AM: Genetic variants of the renin-angiotensin system, diabetic nephropathy, and hypertension. Diabetologia 40: 193-199, 1997
22. Fukushima T, Nomura S, Kawai S, Osawa G: ACE genotype and progression of IgA nephropathy [Letter]. Lancet 346: 571, 1995
23. Opelz G, Mytilineos J, Scherer S, Dunckley H, Trejaut J, Chapman J, Middleton D, Savage D, Fischer O, Bignon JD, Bensa JC, Ekkehard A, Harriet N: Survival of DNA HLA-DR typed and matched cadaver kidney transplants: The collaborative transplant study. Lancet 338: 461-463, 1991
24. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332: 706-711, 1995
25. Rumble J: Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in model combining genetic hypertension and diabetes. Am J Hypertens 8: 53-57, 1995
26. Paul LC, Davidoff A, Benediktsson H: Cardiac allograft atherosclerosis in the rat: The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor. Transplantation 57: 1767-1772, 1994
27. Michel JB, Plissonnier D, Bruneval P: Effect of perindopril on the immune arterial wall remodeling in the rat model of arterial graft rejection. Am J Med 92: 39S-46S, 1992
28. Bochicchio T, Sandoval G, Ron O, Perez Grovas H, Bordes J, Herrera Acosta J: Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensives. Kidney Int 38: 873-879, 1990
29. Gaciong ZA, Religa P, Placha G, Rell K, Paczek L: ACE genotype and progression of IgA nephropathy [Letter]. Lancet 346: 570, 1995
30. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F: Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet 58: 1268-1278, 1996
31. Hingorani AD, Jia HY, Stevens PA, Hopper R, Dickerson JEC, Brown MJ: Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 13: 1602-1609, 1995